Neoadjuvant Chemo New SOC Option in Urothelial Carcinoma Neoadjuvant Chemo New SOC Option in Urothelial Carcinoma

Neoadjuvant chemotherapy in the high-risk population demonstrated favorable pathologic responses, and was well tolerated.Medscape Medical News
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news